US 10-Year Yield Tops 5% a Day Before FOMC, KOSPI Battles to Hold 6,600 Line

A joint investigation and response unit has reportedly begun investigating a biotech company's headquarters and employees over suspected insider trading. The company's stock had repeatedly shown a pattern of sharp swings around each disclosure, with indications that insiders had purchased shares just ahead of disclosures and then immediately dumped their holdings once the disclosure pushed the price up. It was noted that even when genuinely positive news broke, the stock would wobble from the outset as insiders' pre-positioned buy and sell orders flooded the market first. Given that the president himself has stated that unfair trading in capital markets will be dealt with severely enough to embarrass the companies involved, legal penalties are expected to be strengthened, with calls for a full review not just of this case but of the company's entire trading history.

An exclusive report also revealed that a fund manager overseeing a KOSDAQ active fund at an asset management firm is under investigation by the Financial Supervisory Service on suspicion of front-running. The fund had drawn market attention for its active strategy of aggressively raising the weighting of promising stocks rather than simply tracking index weightings, but it was reported that, before the fund disclosed its holdings, the manager in question used hard-to-trace methods such as borrowed-name accounts and tethering to buy the same stocks in advance. The case was assessed as particularly serious given that it exploited the very mechanism by which the fund discloses its stock weightings to the market, effectively amounting to front-running against the market as a whole.

It was repeatedly emphasized that the asset management industry is fundamentally built on investor trust. Given that the term investment trust itself conveys the idea of investors entrusting their funds to a manager they trust, front-running that betrays this trust was described as an issue that undermines the credibility of the entire industry, not merely an individual manager's misconduct. Calls were made for disclosing the manager's identity, an official apology from the asset management firm, a full compliance review covering all fund managers, and even pursuing measures to disclose the identities of those responsible should similar incidents recur in the future.

Throughout the first half of this year, Hyundai Motor actively promoted its humanoid robotics business with Boston Dynamics, including through World Cup advertising. Yet the negative news that the IPO timeline has become uncertain surfaced not through an official company statement, but through a report citing remarks from a senior executive speaking on condition of anonymity. This was criticized as a strategic failure to fulfill the company's accountability to investors and the market — stepping forward when building momentum, but quietly leaking unfavorable news from behind a cloak of anonymity.

It was noted that an initial public offering, by definition, means opening up the company to attract investor capital, and therefore requires the company to present the market with a clear plan and accountable explanation to match. Given that many investors have made investment decisions based on Hyundai Motor's robotics business, the view offered was that top management needs to directly present a clear business plan in response to the uncertainty the company itself has created.